OneAscent Family Office, LLC
Family OfficePosition in LLY — ELI LILLY & Co
CIK 2055812
BIRMINGHAM, AL
Position in LLY
as of Jun 30, 2026
· filed Aug 11, 2026
Position Value
$1,122,666
+$463,191 QoQ
Shares Held
936
+30.5% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.99%
of 13F equity value
Holder Rank
#3,028
of 4,605 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in LLY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026OneAscent Family Office, LLC holds $5,104,910 across 9 Drug Manufacturers - General names. LLY ranks #1 (22.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
This page
|
936 | $1,122,666 | |
| 2 | MRK |
Merck & Co., Inc.
|
6,470 | $831,395 | |
| 3 | ABBV |
AbbVie Inc.
|
2,819 | $709,373 | |
| 4 | GILD |
Gilead Sciences, Inc.
|
4,802 | $606,684 | |
| 5 | NVS |
Novartis AG
|
3,508 | $549,773 | |
| 6 | AZN |
Astrazeneca PLC
|
2,581 | $489,409 | |
| 7 | AMGN |
Amgen Inc
|
874 | $316,492 | |
| 8 | BMY |
Bristol Myers Squibb Co
|
4,344 | $250,301 |
All Filings in LLY
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $1,122,666 | 936 | Shares | Sole | 2026-08-11 | |
| 2026-03-31 | $659,475 | 717 | Shares | Sole | 2026-04-21 | |
| 2025-12-31 | $682,421 | 635 | Shares | Sole | 2026-02-11 | |
| 2025-09-30 | $420,413 | 551 | Shares | Sole | 2025-10-31 | |
| 2025-06-30 | $417,048 | 535 | Shares | Sole | 2025-08-06 | |
| 2025-03-31 | $756,532 | 916 | Shares | Sole | 2025-05-05 | |
| 2024-12-31 | $332,732 | 431 | Shares | Sole | 2025-02-12 | |
| No filing history on record for this holder in this stock. | ||||||